<h1>It should be noted that for the enthesitis questions (PICO 49, 50, and 51), the existing evidence was mainly drawn from the apremilast studies, as no randomized controlled trial report described enthesitis outcomes for the other OSMs.</h1>

<h1>Table 6. Recommendations for treatment of patients with active psoriatic arthritis and comorbidities, including concomitant diabetes and recurrent serious infections (PICOs 63â€“66)*</h1>